AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) Short Interest Down 68.3% in July

AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) was the recipient of a significant decrease in short interest in the month of July. As of July 31st, there was short interest totaling 11,000 shares, adecreaseof68.3% from the July 15th total of 34,700 shares. Based on an average trading volume of 258,000 shares, the days-to-cover ratio is presently 0.0 days. Based on an average trading volume of 258,000 shares, the days-to-cover ratio is presently 0.0 days.

AXIM Biotechnologies Stock Performance

OTCMKTS:AXIM opened at $0.01 on Monday. The company’s fifty day moving average price is $0.01 and its 200-day moving average price is $0.01. AXIM Biotechnologies has a 1-year low of $0.00 and a 1-year high of $0.01.

AXIM Biotechnologies Company Profile

AXIM Biotechnologies, Inc engages in the development and sale of diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases. The company is developing tests for dye eye diseases; SARS-CoV-2 neutralizing antibody tests; and fentanyl neutralizing antibody tests. It also developing a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring.